WCCT Global is a Full Service CRO focused on the development of specialized treatments and medicines in service of the pharmaceutical, biotechnology, and medical device industries. We are experts in early clinical development and have conducted hundreds of Phase I clinical trials at our corporate owned-and operated clinical pharmacology units across the Southern California region. In addition to our expertise in early clinical development, we are capable of providing back-end management services for multi-site Late Phase (Phase II-IV) development programs in a number of therapeutic areas. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, clinical data management, patient recruitment, and strategic consulting support, with an emphasis on executing trials in special disease and pediatric populations.
WCCT is known throughout the industry for its innovative approach to clinical trial design, with the ultimate goal of expediting drug development for the global market. Thus, WCCT is an industry leader in Ethnobridging, also known as ethnic sensitivity trials, where specific ethnic groups which mirror international populations–specifically from Japan–are incorporated into study design to provide data for populations outside of the United States. Through this methodology, drug development is expedited in the global market, resulting in significant savings in development costs.
Furthermore, WCCT Global owns the only Influenza Challenge research facility in the United States, and the second facility of its kind worldwide. At this facility, WCCT is able to contribute to the development of vaccines for influenza and other infectious diseases, utilizing the Viral Challenge Model. This type of research has proven to be just as effective as field studies for infectious diseases, and infinitely easier to recruit for, eliminating seasonal constraints and limited access to the correct patient populations as obstacles.
As a Full Service CRO (contract research organization), WCCT has committed to excellence in a number of therapeutic areas, with a CPU site network as well as providing CRO services for all trial phases. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Gastroenterology, Oncology Renal, and Vaccines. Our commitment is to the continued development of these and new therapeutic ares of excellence. For questions regarding our capabilities or experience in early or late phase development, our Phase I-IV clinical pharmacology units and outpatient centers, or patient recruitment, please contact us today!